(ASUR) Asure Software - Overview
Stock: Payroll, Tax, Hr, Time, Recruiting
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 47.7% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha | -39.64 |
| Character TTM | |
|---|---|
| Beta | 0.952 |
| Beta Downside | 1.035 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.42% |
| CAGR/Max DD | -0.10 |
Description: ASUR Asure Software December 31, 2025
Asure Software (NASDAQ: ASUR) delivers cloud-based Human Capital Management (HCM) SaaS primarily to U.S. small- and mid-size enterprises, offering an integrated payroll-tax engine, HR compliance tools, time-and-attendance tracking, talent acquisition, and a marketplace for third-party integrations. The firm’s “Total HR” and “Strategic HR” services aim to replace in-house HR functions, positioning Asure as a one-stop outsourcing platform for compliance-heavy SMBs.
Based on the latest earnings release (Q3 2024), Asure reported $150 million in revenue, a 12 % year-over-year increase, and a trailing twelve-month ARR of roughly $200 million with an estimated net churn rate of 5 %. The payroll-tax segment now contributes about 55 % of revenue, reflecting growing demand for automated tax credit filing (e.g., ERC) among mid-market employers. Macro-level, U.S. SMB SaaS spending is expanding at ~8 % YoY, driven by digital transformation budgets and tighter labor-regulation environments.
Given the competitive landscape-dominated by larger players like Paychex and ADP-Asure’s growth hinges on retaining low churn while expanding its marketplace ecosystem. Investors should monitor the company’s ARR growth trajectory, gross margin trends, and the pace of adoption of its “AsureMarketplace” integrations, as these drivers will materially affect valuation multiples. For a deeper quantitative view, the ValueRay platform provides a granular breakdown of ASUR’s valuation multiples and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -17.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 6.37 > 1.0 |
| NWC/Revenue: 11.24% < 20% (prev 12.52%; Δ -1.28% < -1%) |
| CFO/TA 0.05 > 3% & CFO 20.7m > Net Income -17.1m |
| Net Debt (55.6m) to EBITDA (8.57m): 6.49 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.6m) vs 12m ago 4.30% < -2% |
| Gross Margin: 67.10% > 18% (prev 0.59%; Δ 6651 % > 0.5%) |
| Asset Turnover: 30.17% > 50% (prev 26.92%; Δ 3.25% > 0%) |
| Interest Coverage Ratio: -3.46 > 6 (EBITDA TTM 8.57m / Interest Expense TTM 3.59m) |
Altman Z'' -3.64
| A: 0.03 (Total Current Assets 193.1m - Total Current Liabilities 178.3m) / Total Assets 447.1m |
| B: -0.72 (Retained Earnings -321.1m / Total Assets 447.1m) |
| C: -0.03 (EBIT TTM -12.4m / Avg Total Assets 437.6m) |
| D: -1.26 (Book Value of Equity -320.5m / Total Liabilities 254.0m) |
| Altman-Z'' Score: -3.64 = D |
Beneish M -3.22
| DSRI: 0.74 (Receivables 14.6m/17.2m, Revenue 132.0m/115.3m) |
| GMI: 0.88 (GM 67.10% / 58.85%) |
| AQI: 1.20 (AQ_t 0.50 / AQ_t-1 0.42) |
| SGI: 1.15 (Revenue 132.0m / 115.3m) |
| TATA: -0.08 (NI -17.1m - CFO 20.7m) / TA 447.1m) |
| Beneish M-Score: -3.22 (Cap -4..+1) = AA |
What is the price of ASUR shares?
Over the past week, the price has changed by -7.38%, over one month by -5.01%, over three months by +9.19% and over the past year by -23.32%.
Is ASUR a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ASUR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.2 | 48.4% |
| Analysts Target Price | 13.2 | 48.4% |
| ValueRay Target Price | 8.5 | -4.3% |
ASUR Fundamental Data Overview February 02, 2026
P/S = 2.0231
P/B = 1.3833
P/EG = 0.5025
Revenue TTM = 132.0m USD
EBIT TTM = -12.4m USD
EBITDA TTM = 8.57m USD
Long Term Debt = 64.2m USD (from longTermDebt, last quarter)
Short Term Debt = 8.08m USD (from shortTermDebt, last quarter)
Debt = 77.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.6m USD (from netDebt column, last quarter)
Enterprise Value = 322.7m USD (267.1m + Debt 77.2m - CCE 21.5m)
Interest Coverage Ratio = -3.46 (Ebit TTM -12.4m / Interest Expense TTM 3.59m)
EV/FCF = 75.87x (Enterprise Value 322.7m / FCF TTM 4.25m)
FCF Yield = 1.32% (FCF TTM 4.25m / Enterprise Value 322.7m)
FCF Margin = 3.22% (FCF TTM 4.25m / Revenue TTM 132.0m)
Net Margin = -12.94% (Net Income TTM -17.1m / Revenue TTM 132.0m)
Gross Margin = 67.10% ((Revenue TTM 132.0m - Cost of Revenue TTM 43.4m) / Revenue TTM)
Gross Margin QoQ = 63.84% (prev 66.10%)
Tobins Q-Ratio = 0.72 (Enterprise Value 322.7m / Total Assets 447.1m)
Interest Expense / Debt = 2.55% (Interest Expense 1.97m / Debt 77.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -9.80m (EBIT -12.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.08 (Total Current Assets 193.1m / Total Current Liabilities 178.3m)
Debt / Equity = 0.40 (Debt 77.2m / totalStockholderEquity, last quarter 193.1m)
Debt / EBITDA = 6.49 (Net Debt 55.6m / EBITDA 8.57m)
Debt / FCF = 13.08 (Net Debt 55.6m / FCF TTM 4.25m)
Total Stockholder Equity = 195.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.90% (Net Income -17.1m / Total Assets 447.1m)
RoE = -8.74% (Net Income TTM -17.1m / Total Stockholder Equity 195.6m)
RoCE = -4.77% (EBIT -12.4m / Capital Employed (Equity 195.6m + L.T.Debt 64.2m))
RoIC = -4.14% (negative operating profit) (NOPAT -9.80m / Invested Capital 236.7m)
WACC = 7.76% (E(267.1m)/V(344.3m) * Re(9.42%) + D(77.2m)/V(344.3m) * Rd(2.55%) * (1-Tc(0.21)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.20%
[DCF Debug] Terminal Value 71.34% ; FCFF base≈4.25m ; Y1≈2.79m ; Y5≈1.27m
Fair Price DCF = N/A (negative equity: EV 26.0m - Net Debt 55.6m = -29.6m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -19.01 | EPS CAGR: -10.93% | SUE: -1.92 | # QB: 0
Revenue Correlation: 76.92 | Revenue CAGR: 15.51% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.26 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=0.91 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+37.0% | Growth Revenue=+14.0%